V., McGehee, S., Ouwerkerk, R., Raisinger, K., Rozga, I., Zhou, M
Evolving Peptide Therapy: Safety and Evidence First As peptide therapy continues to evolve, the focus remains on: Safety: Understanding short- and long-term risk profiles Regulatory compliance: Using peptides that fit within current FDA and compounding regulations Scientific support: Prioritizing treatments backed by clinical data, not just anecdotal reports Individualization: Matching each patients treatment plan to their medical history, goals, and risk tolerance Potential Alternatives to Ipamorelin and CJC-1295: Tesamorelin and Hexarelin Tesamorelin and Hexarelin illustrate how newer or alternative peptides can help fill the gap left by Ipamorelin and CJC-1295
The recurring fee is the price of continuity, not a single drug purchase
A study published in the Journal of Clinical Endocrinology & Metabolism showed that Sermorelin administration can increase lean body mass and reduce body fat